J B Chemicals and Pharmaceuticals Ltd
JB Pharma's GHG Emissions Data Preview
In 2025, JB Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, JB Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
b
b
b
b
b
b
b
b
bVerified Sources Behind JB Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore JB Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into JB Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of JB Pharma amounted to 54,408.46 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of JB Pharma increased by 14.13%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
JB Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are JB Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of JB Pharma were 5,651.98 metric tons of CO₂ equivalent (tCO₂e). a
Has JB Pharma reduced its Scope 1 emissions over time?
Since 2021, JB Pharma's Scope 1 emissions have decreased by 33.07%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), JB Pharma's Scope 1 emissions decreased by 34.96%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are JB Pharma's Scope 2 emissions?
In 2025, JB Pharma reported Scope 2 greenhouse gas (GHG) emissions of 48,756.48 tCO₂e without specifying the calculation method. a
Has JB Pharma reduced its Scope 2 emissions over time?
Since 2021, JB Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that JB Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2024), JB Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 25.08% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does JB Pharma use for Scope 2 reporting?
In 2025, JB Pharma reported its Scope 2 emissions using an unspecified methodology. a
JB Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into JB Pharma's Value Chain Emissions
In 2025, JB Pharma reported 219,076 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of JB Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
JB Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are JB Pharma's Scope 3 emissions?
In 2025, JB Pharma reported total Scope 3 emissions of 219,076 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2024), JB Pharma's Scope 3 emissions increased by 16.16%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into JB Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, JB Pharma reported Scope 1 greenhouse gas (GHG) emissions of 5,651.98 tCO₂e and total revenues of USD 452 millions. This translates into an emissions intensity of 12.5 tCO₂e per millions USD. a
JB Pharma's Scope 1 Emissions Intensity Compared to Peers
How does JB Pharma's GHG emissions intensity compare to its peers?
In 2025, JB Pharma reported a Scope 1 emissions intensity of 12.5 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does JB Pharma rank on GHG emissions intensity within its industry?
In 2025, JB Pharma ranked 7 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
JB Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into JB Pharma's Total Carbon Footprint
In 2025, JB Pharma reported a total carbon footprint of 273,484.46 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 15.75% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to JB Pharma's total carbon footprint was Scope 3 emissions, accounting for 80.11% of the company's total carbon footprint, followed by Scope 2 emissions at 17.83%. a